Most influenza viruses enter human or animal cells through specific pathways on the cells’ surface. Researchers at the University of Zurich have now discovered that certain human flu viruses and avian flu viruses can also use a second entry pathway, a protein complex of the immune system, to infect cells.
Bristol Myers Squibb Expands Oncology Portfolio with Mirati Acquisition – Pharmaceutical Technology
Through the acquisition, Bristol Myers Squibb will be able to diversify its oncology portfolio with targeted therapies such as Krazati. Credit: nitpicker via Shutterstock. On
October 16, 2023